Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biovaxys Technology Corp (BVAXF)

Biovaxys Technology Corp (BVAXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BVAXF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0300 +79.00%
on 07/15/24
0.0545 -1.47%
on 07/10/24
+0.0037 (+7.40%)
since 06/25/24
3-Month
0.0300 +79.00%
on 07/15/24
0.0625 -14.08%
on 05/02/24
-0.0088 (-14.08%)
since 04/25/24
52-Week
0.0091 +490.11%
on 12/08/23
0.0758 -29.16%
on 02/26/24
+0.0384 (+250.98%)
since 07/26/23

Most Recent Stories

More News
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it intends to complete a non-brokered...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
BIOVAXYS ANNOUNCES ISSUANCE OF DPX RELATED PATENT FROM THE U.S. PATENT AND TRADEMARK OFFICE

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that the United States Patent and Trademark Office...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Brittany Davison, CPA, CA...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF TRIAL TO TEST IMMUNOCONTRACEPTION IN ASIAN ELEPHANTS

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac-for-Wildlife, Inc. ("SpayVac") jointly announce that SpayVac...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
BioVaxys Technology Corp. Announces Revocation of Cease Trade Order

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: BVAXF) (the "Company") is pleased to announce the revocation of the failure to file cease trade...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") announces that the Ontario Securities Commission (the "OSC") has...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050

/CNW/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
MRNA : 122.11 (+1.42%)
BOLD : 3.71 (-0.80%)
IBRX : 5.61 (+2.19%)
MGNX : 5.55 (+0.91%)
Promising Outlook as Biotech Sector Advances Cancer Treatments Amidst Rising Diagnoses

USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society...

BRX : 24.56 (+1.49%)
BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)
MRNA : 122.11 (+1.42%)
BOLD : 3.71 (-0.80%)
IBRX : 5.61 (+2.19%)
MGNX : 5.55 (+0.91%)
BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has appointed Christopher Cherry as...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0537 (+2.68%)

Key Turning Points

3rd Resistance Point 0.0621
2nd Resistance Point 0.0580
1st Resistance Point 0.0558
Last Price 0.0537
1st Support Level 0.0495
2nd Support Level 0.0454
3rd Support Level 0.0432

See More

52-Week High 0.0758
Last Price 0.0537
Fibonacci 61.8% 0.0503
Fibonacci 50% 0.0424
Fibonacci 38.2% 0.0346
52-Week Low 0.0091

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar